Profil
Olivia Lai formerly worked at US-China Biomedical Technology, Inc., as Independent Director from 2015 to 2017 and Global Future City Holding, Inc., as Associate.
Ms. Lai received her graduate degree from the University of Southern California.
Anciens postes connus de Olivia Lai
| Sociétés | Poste | Fin |
|---|---|---|
| US-CHINA BIOMEDICAL TECHNOLOGY, INC. | Director/Board Member | 23/06/2017 |
| GLOBAL FUTURE CITY HOLDING INC. | Corporate Officer/Principal | - |
Formation de Olivia Lai
| University of Southern California | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Global Future City Holding, Inc.
 Global Future City Holding, Inc. RestaurantsConsumer Services Global Future City Holding, Inc. was a holding company, which was engages in the sale of consumer product. It use to offer its products through the GX-Life Direct Selling Program operated by its subsidiary. The company was founded on October 12, 2000 and was headquartered in Irvine, CA. | Consumer Services |
US-China Biomedical Technology, Inc.
 US-China Biomedical Technology, Inc. Packaged SoftwareTechnology Services US-China Biomedical Technology, Inc. is an early stage biomedical technology and services company. It engages in marketing and sales in the United States of products and technology developed by BSP Medical Ltd, which offers a non-invasive diagnosis of cardiac diseases and electrocardiogram (“ECG”) products based on the HyperQ™ technology. The company was founded by Safa Movassaghi on December 20, 2010 and is headquartered in Irvine, CA. | Technology Services |
